Pharmacoepidemiology and Drug Safety

Cover image for Vol. 20 Issue 2

February 2011

Volume 20, Issue 2

Pages 111–218

  1. Original Reports

    1. Top of page
    2. Original Reports
    3. Brief Reports
    4. Commentaries
    1. Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study (pages 111–118)

      Daniel Mines, Yun Gu, Tzuyung Doug Kou and Gregory S Cooper

      Version of Record online: 9 DEC 2010 | DOI: 10.1002/pds.2057

    2. Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors (pages 131–137)

      Karen J. Wernli, John M. Hampton, Amy Trentham-Dietz and Polly A. Newcomb

      Version of Record online: 8 NOV 2010 | DOI: 10.1002/pds.2064

    3. Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy (pages 138–145)

      Robert L. Davis, David Eastman, Heather McPhillips, Marsha A. Raebel, Susan E Andrade, David Smith, Marianne Ulcickas Yood, Sascha Dublin and Richard Platt

      Version of Record online: 15 NOV 2010 | DOI: 10.1002/pds.2068

    4. Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study (pages 146–153)

      Jonas Bjerring Olesen, Peter Riis Hansen, Steen Zabell Abildstrøm, Charlotte Andersson, Peter Weeke, Michelle Schmiegelow, Jesper Erdal, Christian Torp-Pedersen and Gunnar Hilmar Gislason

      Version of Record online: 9 DEC 2010 | DOI: 10.1002/pds.2073

    5. Self-reported prevalence of hypersensitivity reactions against drugs among medical students: does awareness cause any difference? (pages 154–161)

      Sevim Bavbek, Ferda Öner Erkekol, Gülfem Elif Çelik, İpek Gönüllü and Zeynep Mısırlıgil

      Version of Record online: 7 DEC 2010 | DOI: 10.1002/pds.2076

    6. Definition of patients treated with evidence based drugs in absence of prescribed daily doses: the example of acute myocardial infarction (pages 169–176)

      Valeria Belleudi, Danilo Fusco, Ursula Kirchmayer, Nera Agabiti, Mirko Di Martino, Silvia Narduzzi, Marina Davoli, Massimo Arcà and Carlo Alberto Perucci

      Version of Record online: 9 DEC 2010 | DOI: 10.1002/pds.2079

    7. Increasing off-label use of antipsychotic medications in the United States, 1995–2008 (pages 177–184)

      G. C. Alexander, S. A. Gallagher, A. Mascola, R. M. Moloney and R. S. Stafford

      Version of Record online: 6 JAN 2011 | DOI: 10.1002/pds.2082

    8. Impact of implementing alerts about medication black-box warnings in electronic health records (pages 192–202)

      Donghui Tony Yu, Diane L. Seger, Karen E. Lasser, Andrew S. Karson, Julie M. Fiskio, Andrew C. Seger and David W. Bates

      Version of Record online: 28 DEC 2010 | DOI: 10.1002/pds.2088

  2. Brief Reports

    1. Top of page
    2. Original Reports
    3. Brief Reports
    4. Commentaries
  3. Commentaries

    1. Top of page
    2. Original Reports
    3. Brief Reports
    4. Commentaries

SEARCH

SEARCH BY CITATION